Persona Revision Knee System Outcomes

NCT ID: NCT04821154

Last Updated: 2025-10-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

380 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-14

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will evaluate the performance, clinical benefits and safety of the Persona Revision Knee System in patients who have received primary or revision total knee arthroplasty (TKA) treatment. This will be done using a multicenter, single-arm, consecutive series, retrospective cohort study with prospective follow-up.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Under study are the Persona® Revision Knee System (K181947 and K191625) implants and instrumentation, and any compatible devices being used in conjunction according to the Instructions for Use. This will be accomplished by retrospectively identifying patients who underwent primary or revision TKA with this system and inviting them to participate in prospective data collection at 1, 2, 3, 4, 5, 7, and 10 years postoperative follow-up. As the device was not available for commercial use until late 2019, the retrospective portion will involve those activities that occurred per standard of care for participants.

The primary endpoint for this study will be performance assessed by improvement in the 1989 Knee Society Clinical Rating System (KS) objective knee score (KS-KS) from baseline to 2 years (as evaluated using the overall group mean showing at least the Minimal Clinically Important Difference (MCID) of 5.4 points).

A maximum of 20 sites will contribute to this study. There will be a maximum of 380 patients enrolled in the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Arthroplasty Complications Infection Knee Disease Knee Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1) Revision Splined CCK

Patients who were implanted with a splined tibial stem, 0 degree Persona Revision tibial component, constrained condylar knee (CCK) articular surface, Persona Revision femoral component, and splined femoral stem.

Persona Revision Knee System

Intervention Type DEVICE

Patients in this cohort will have been previously implanted with the Persona Revision Knee system in the described configuration per standard of care. The Persona Revision knee system is a total knee system that is widely available for use in the United States and is designed for use in primary and revision knee surgical interventions.

2) Revision Cemented CCK

Patients who were implanted with a cemented tibial stem, 0 degree Persona Revision tibial component, CCK articular surface, Persona Revision femoral component, and cemented femoral stem.

Persona Revision Knee System

Intervention Type DEVICE

Patients in this cohort will have been previously implanted with the Persona Revision Knee system in the described configuration per standard of care. The Persona Revision knee system is a total knee system that is widely available for use in the United States and is designed for use in primary and revision knee surgical interventions.

3) Revision Splined PS/CPS

Patients who were implanted with a splined tibial stem, 0 degree Persona Revision tibial component, posterior stabilized/constrained posterior stabilized (PS/CPS) articular surface, Persona Revision femoral component, and splined femoral stem.

Persona Revision Knee System

Intervention Type DEVICE

Patients in this cohort will have been previously implanted with the Persona Revision Knee system in the described configuration per standard of care. The Persona Revision knee system is a total knee system that is widely available for use in the United States and is designed for use in primary and revision knee surgical interventions.

4) Revision Cemented PS/CPS

Patients who were implanted with a cemented tibial stem, 0 degree Persona Revision tibial component, PS/CPS articular surface, Persona Revision femoral component, and cemented femoral stem.

Persona Revision Knee System

Intervention Type DEVICE

Patients in this cohort will have been previously implanted with the Persona Revision Knee system in the described configuration per standard of care. The Persona Revision knee system is a total knee system that is widely available for use in the United States and is designed for use in primary and revision knee surgical interventions.

5) Revision Splined PS/CPS

Patients who were implanted with a splined tibial stem, 0 degree Persona Revision tibial component, PS/CPS articular surface, Persona primary PS femoral component, with no femoral stem.

Persona Revision Knee System

Intervention Type DEVICE

Patients in this cohort will have been previously implanted with the Persona Revision Knee system in the described configuration per standard of care. The Persona Revision knee system is a total knee system that is widely available for use in the United States and is designed for use in primary and revision knee surgical interventions.

6) Revision Cemented PS/CPS

Patients who were implanted with a cemented tibial stem, 0 degree Persona Revision tibial component, PS/CPS articular surface, Persona primary PS femoral component, with no femoral stem.

Persona Revision Knee System

Intervention Type DEVICE

Patients in this cohort will have been previously implanted with the Persona Revision Knee system in the described configuration per standard of care. The Persona Revision knee system is a total knee system that is widely available for use in the United States and is designed for use in primary and revision knee surgical interventions.

7) Revision Cemented CCK with 5 Degree Primary Tibia

Patients who were implanted with a cemented tibial stem, 5 degree Persona primary tibial component, CCK articular surface, Persona Revision femoral component, and cemented femoral stem.

Persona Revision Knee System

Intervention Type DEVICE

Patients in this cohort will have been previously implanted with the Persona Revision Knee system in the described configuration per standard of care. The Persona Revision knee system is a total knee system that is widely available for use in the United States and is designed for use in primary and revision knee surgical interventions.

8) Primary Splined CCK/CPS/PS with 0 Degree Tibia

Patients with a primary implant (non-revision case) who were implanted with a splined tibial stem, 0 degree Persona Revision tibial component, CCK/PS/CPS articular surface, Persona Revision femoral component, and splined femoral stem.

Persona Revision Knee System

Intervention Type DEVICE

Patients in this cohort will have been previously implanted with the Persona Revision Knee system in the described configuration per standard of care. The Persona Revision knee system is a total knee system that is widely available for use in the United States and is designed for use in primary and revision knee surgical interventions.

9) Primary Cemented CCK/PS/CPS with 0 Degree Tibia

Patients with a primary implant (non-revision case) who were implanted with a cemented tibial stem, 0 degree Persona Revision tibial component, CCK/PS/CPS articular surface, Persona Revision femoral component, and cemented femoral stem.

Persona Revision Knee System

Intervention Type DEVICE

Patients in this cohort will have been previously implanted with the Persona Revision Knee system in the described configuration per standard of care. The Persona Revision knee system is a total knee system that is widely available for use in the United States and is designed for use in primary and revision knee surgical interventions.

10) Primary Cemented CCK/PS/CPS with 5 Degree Primary Tibia

Patients with a primary implant (non-revision case) who were implanted with a cemented tibial stem, 5 degree Persona primary tibial component, CCK/PS/CPS articular surface, Persona Revision femoral component, and cemented femoral stem.

No interventions assigned to this group

11) Infection Cases

Any configuration of PRK components used for end stage (non-temporary) treatment

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Persona Revision Knee System

Patients in this cohort will have been previously implanted with the Persona Revision Knee system in the described configuration per standard of care. The Persona Revision knee system is a total knee system that is widely available for use in the United States and is designed for use in primary and revision knee surgical interventions.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Male or female of at least 18 years of age at the time of screening.
2. Signed an institutional review board approved informed consent.
3. Willingness and ability to comply with the study procedures and visit schedules and ability to understand and follow oral and written post-operative care instructions.
4. Previous medical diagnosis/ history of at least one of the following conditions requiring treatment using the Persona Revision Knee System within a pre-specified study variant configuration (cohort), in accordance with the instructions for use (IFU):

1. Rheumatoid arthritis, osteoarthritis, traumatic arthritis or polyarthritis
2. Collagen disorders, and/or avascular necrosis of the femoral condyle
3. Post-traumatic loss of joint configuration, particularly when there is patellofemoral erosion, dysfunction or prior patellectomy
4. Moderate valgus, varus, or flexion deformities
5. The salvage of previously failed surgical attempts or for a knee in which satisfactory stability in flexion cannot be obtained at the time of surgery
5. A pre-operative Knee Society Knee Score (objective assessment) ≤ 80.

Exclusion Criteria

1\) Presence of clinically observed active or suspected latent infection in the affected joint at the time of procedure.

3\) Presence of of local/systemic/distant focal infection that may affect or hematogenously spread to the prosthetic joint.

4\) Skeletal immaturity or insufficient bone stock on femoral or tibial surfaces which cannot provide adequate support and/or fixation to the prosthesis.

5\) Diagnosed with neuropathic arthropathy, osteoporosis, or any loss of musculature or neuromuscular disease that compromises the affected limb.

6\) Presence of a stable, painless arthrodesis in a satisfactory functional position in the affected joint.

7\) Severe instability of the affected joint secondary to the absence of collateral ligament integrity.

8\) Diagnosis of rheumatoid arthritis in conjunction with any of the following at the time of screening:

1. An ulcer of the skin
2. History of recurrent breakdown of the skin
3. Use of steroids

9\) Patient requires simultaneous bilateral knee surgery for treatment of diagnosed condition.

10\) Pregnant or women planning to become pregnant during the time they will be participating in the study.

11\) Any documented clinically significant degree of cognitive impairment or other condition, finding, or psychiatric illness at screening which, in the opinion of the Investigator, could compromise patient safety or interfere with the assessment of the safety and treatment effects of the study procedure.

12\) Any patient who is institutionalized, or with a known drug or alcohol dependence currently or within the last year.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zimmer Biomet

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Charles Jaggard

Role: STUDY_DIRECTOR

Zimmer Biomet

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Advanced Orthopaedic Specialists

Fayetteville, Arkansas, United States

Site Status RECRUITING

Bowen Hefley Orthopedics

Little Rock, Arkansas, United States

Site Status RECRUITING

Community Foundation Medical Group

Fresno, California, United States

Site Status WITHDRAWN

Cornerstone Orthopaedics & Sports Medicine

Superior, Colorado, United States

Site Status COMPLETED

Orthopaedic Associates, Inc.

Evansville, Indiana, United States

Site Status COMPLETED

Jeff Yergler, LLC

Granger, Indiana, United States

Site Status RECRUITING

Arthroplasty Foundation Inc.

Louisville, Kentucky, United States

Site Status COMPLETED

Ascension Providence Rochester Hospital

Rochester, Michigan, United States

Site Status RECRUITING

Michigan Orthopaedic Surgeons, PLLC

Southfield, Michigan, United States

Site Status ACTIVE_NOT_RECRUITING

TRIA Orthopaedic Center Research Institute

Bloomington, Minnesota, United States

Site Status COMPLETED

Thomas Aleto MD, PC

Columbia, Missouri, United States

Site Status WITHDRAWN

Orthopaedic Research Institute of New Jersey

Chester, New Jersey, United States

Site Status RECRUITING

The Cleveland Clinic Foundation

Cleveland, Ohio, United States

Site Status RECRUITING

ROC Orthopedics

Oregon City, Oregon, United States

Site Status COMPLETED

Penn Medicine/ Lancaster General Health

Lancaster, Pennsylvania, United States

Site Status COMPLETED

Orthopedic Surgeons of Wisconsin, SC

Wauwatosa, Wisconsin, United States

Site Status WITHDRAWN

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Chelsea Smith

Role: CONTACT

714-740-9438

Charles Jaggard

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Sydney Dale

Role: primary

479-316-4785

Jackie Ross

Role: primary

501-663-6455

Derek Yocum, PhD

Role: primary

865-360-9042

Emma Housholder

Role: backup

574-222-1822

Kayla Chattinger

Role: primary

248-609-9137

Melissa Hough

Role: primary

908-684-3005

Alison Klika

Role: primary

Anabelle Visperas

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CMG2019-13K

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cemented vs Cementless Persona Keel RCT
NCT05630053 ACTIVE_NOT_RECRUITING NA
Persona Cohort Nordic Multicenter Study
NCT03495232 ACTIVE_NOT_RECRUITING
Clinical Outcomes of MP Persona vs. Persona Knee-PS
NCT03681977 ENROLLING_BY_INVITATION NA
Persona Versus NexGen
NCT02269254 COMPLETED NA
Persona Ti-Nidium Post-Market Clinical Follow-up
NCT04817969 ACTIVE_NOT_RECRUITING NA
Persona SoluTion PPS Femur PMCF
NCT07286513 NOT_YET_RECRUITING